Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for Q8CH02

Entry ID Method Resolution Chain Position Source
1UG0 NMR - A 165-239 PDB
1X4O NMR - A 250-314 PDB
AF-Q8CH02-F1 Predicted AlphaFoldDB

21 variants for Q8CH02

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388987762 74 H>R No EVA
rs3388991666 94 K>R No EVA
rs3388939026 96 Q>H No EVA
rs3411191482 149 P>H No EVA
rs3388939074 186 R>I No EVA
rs3388984646 250 K>E No EVA
rs3388973777 308 K>R No EVA
rs235285933 310 D>E No EVA
rs261919057 323 F>L No EVA
rs214626381 324 P>S No EVA
rs13471212 326 P>L No EVA
rs3388984715 335 K>N No EVA
rs3388984712 340 A>S No EVA
rs3399428795 392 V>M No EVA
rs3399254235 407 S>T No EVA
rs3388973702 427 V>M No EVA
rs3388939046 467 Q>H No EVA
rs3388969208 565 Y>* No EVA
rs3388979925 567 M>R No EVA
rs3399205547 611 S>* No EVA
rs3388984035 627 A>P No EVA

No associated diseases with Q8CH02

3 regional properties for Q8CH02

Type Name Position InterPro Accession
domain SWAP/Surp 185 - 239 IPR000061-1
domain SWAP/Surp 260 - 314 IPR000061-2
domain G-patch domain 558 - 607 IPR000467

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
spliceosomal complex Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA.

1 GO annotations of molecular function

Name Definition
RNA binding Binding to an RNA molecule or a portion thereof.

2 GO annotations of biological process

Name Definition
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8IWZ8 SUGP1 SURP and G-patch domain-containing protein 1 Homo sapiens (Human) PR
10 20 30 40 50 60
MSLKMDNRDV AGKANRWFGM AQPKSGKMNM NILHQEELIA QKKREIEARM EQKARQSHVP
70 80 90 100 110 120
SPQPPHPGEI ADAHNSCISN KFANDGSFLQ QFLKLQKAQT STDSAPRAPP SMPTPSSLKK
130 140 150 160 170 180
PLVLSKRTGL GLSSPTGPVK NYSHAKQLPV AHRPSVFQSP DDDEEEDYEQ WLEIKVSPPE
190 200 210 220 230 240
GAETRRVIEK LARFVAEGGP ELEKVAMEDY KDNPAFTFLH DKNSREFLYY RRKVAEIRKE
250 260 270 280 290 300
AQKPQAATQK VSPPEDEEAK NLAEKLARFI ADGGPEVETI ALQNNRENQA FSFLYDPNSQ
310 320 330 340 350 360
GYRYYRQKLD EFRKAKAGST GSFPAPAPNP SLRRKSAPEA LSGAVPPITA CPTPVAPAPA
370 380 390 400 410 420
VNPTPSIPGK PTATAAVKRK RKSRWGPEED KVELPPAELA QRDIDASPSP LSVQDLKGLG
430 440 450 460 470 480
YEKGKPVGLV GVTELSDAQK KQLKEQQEMQ QMYDMIMQHK RAMQDMQLLW EKALQQHQHG
490 500 510 520 530 540
YDSDEEVDSE LGTWEHQLRR MEMDKTREWA EQLTQMGRGK HFIGDFLPPD ELEKFMETFK
550 560 570 580 590 600
ALKEGREPDY SEYKEFKLTV ENIGYQMLMK MGWKEGEGLG TEGQGIKNPV NKGATTIDGA
610 620 630 640
GFGIDRPAEL SKEDDEYEAF RKRMMLAYRF RPNPLNNPRR PYY